Search

Your search keyword '"Michael E. Scheurer"' showing total 408 results

Search Constraints

Start Over You searched for: Author "Michael E. Scheurer" Remove constraint Author: "Michael E. Scheurer"
408 results on '"Michael E. Scheurer"'

Search Results

1. A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care

2. Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinoma

3. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta‐analysis

4. Heritability of nervous system tumors: a sibling-based design

5. A population-based assessment of metastatic hepatoblastoma in Texas reveals ethnic disparities

6. Global molecular alterations involving recurrence or progression of pediatric brain tumors

7. Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia

8. Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis

9. Rare deleterious germline variants and risk of lung cancer

10. A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement

11. Clustering of Pediatric Brain Tumors in Texas, 2000–2017

12. HERVs and Cancer—A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers

13. Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas

14. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial

16. Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia

17. Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease

18. Testosterone versus hCG in Hypogonadotropic Hypogonadism – Comparing Clinical Effects and Evaluating Current Practice

19. Establishing a Pediatric Hematology-Oncology Program in Botswana

20. Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi

21. Elastin‐Specific Autoimmunity in Smokers With Thoracic Aortic Aneurysm and Dissection is Independent of Chronic Obstructive Pulmonary Disease

23. Early Lifestyle Intervention for Obesity Prevention in Pediatric Survivors of Acute Lymphoblastic Leukemia

24. Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi

26. Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings

32. CancerHERVdb: Human Endogenous Retrovirus (HERV) Expression Database for Human Cancer Accelerates Studies of the Retrovirome and Predictions for HERV-Based Therapies

33. Polymorphisms in the non-homologous end-joining DNA repair pathway are associated with HPV integration in cervical dysplasia

35. Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia

36. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor

37. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors

38. Data from Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance

39. All Supplementary Data from Recurrent Patterns of Protein Expression Signatures in Pediatric Acute Lymphoblastic Leukemia: Recognition and Therapeutic Guidance

40. Supplemental Table 1 from Genetic Modulation of Neurocognitive Function in Glioma Patients

41. Suppl. Table 1 from Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study

43. Supplementary Data from Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

44. Data from Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study

45. Data from Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients

46. Data from Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

47. Data from Genetic Modulation of Neurocognitive Function in Glioma Patients

49. Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children’s Oncology Group

50. Cancer risk among RECQL4 heterozygotes

Catalog

Books, media, physical & digital resources